Observational Study on the Safety and Effectiveness of Tepezza (teprotumumab) in South Korea

02/09/2026
20/10/2026
EU PAS number:
EUPAS1000001085
Study
Planned
Documents
Study protocol
Initial protocol
English (1.86 MB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.